Visone Rosa, Russo Lucia, Pallante Pierlorenzo, De Martino Ivana, Ferraro Angelo, Leone Vincenza, Borbone Eleonora, Petrocca Fabio, Alder Hansjuerg, Croce Carlo Maria, Fusco Alfredo
Dipartimento di Biologia e Patologia Cellulare e Molecolare c/o Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, via Pansini, 5, 80131 Naples, Italy.
Endocr Relat Cancer. 2007 Sep;14(3):791-8. doi: 10.1677/ERC-07-0129.
We have recently reported that MicroRNAs (miR)-221 and miR-222 were up-regulated in human thyroid papillary carcinomas in comparison with the normal thyroid tissue. Bioinformatic analysis proposed the p27(Kip1) protein, a key regulator of cell cycle, as a candidate target for the miR-221/222 cluster. Here, we report that the enforced expression of miR-221 and miR-222 was able to reduce p27(Kip1) protein levels in thyroid carcinoma and HeLa cells in the absence of significant changes in specific p27(Kip1) mRNA levels. This effect is direct as miR-221 and miR-222 negatively regulate the expression of the 3'-untranslated region-based reporter construct from the p27(Kip1) gene, and is dependent on two target sites in this region. Consistent with these results, an enforced expression of the miR-221 and miR-222 induced the thyroid papillary carcinoma cell line (TPC-1) to progress to the S phase of the cell cycle. It is likely that the negative regulation of p27(Kip1) by miR-221 and miR-222 might also have a role in vivo since we report an inverse correlation between miR-221 and miR-222 up-regulation and down-regulation of the p27(Kip1) protein levels in human thyroid papillary carcinomas. Therefore, the data reported here demonstrate that miR-221 and miR-222 are endogenous regulators of p27(Kip1) protein expression, and thereby, the cell cycle.
我们最近报道,与正常甲状腺组织相比,微小RNA(miR)-221和miR-222在人甲状腺乳头状癌中上调。生物信息学分析表明,细胞周期的关键调节因子p27(Kip1)蛋白是miR-221/222簇的候选靶标。在此,我们报道,在特定p27(Kip1)mRNA水平无显著变化的情况下,miR-221和miR-222的强制表达能够降低甲状腺癌和HeLa细胞中p27(Kip1)蛋白水平。这种作用是直接的,因为miR-221和miR-222负向调节基于p27(Kip1)基因3'-非翻译区的报告基因构建体的表达,并且依赖于该区域的两个靶位点。与这些结果一致,miR-221和miR-222的强制表达诱导甲状腺乳头状癌细胞系(TPC-1)进入细胞周期的S期。由于我们报道在人甲状腺乳头状癌中miR-221和miR-222上调与p27(Kip1)蛋白水平下调之间呈负相关,因此miR-221和miR-222对p27(Kip1)的负向调节在体内可能也起作用。因此,本文报道的数据表明,miR-221和miR-222是p27(Kip1)蛋白表达的内源性调节因子,从而也是细胞周期的内源性调节因子。